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Breast cancer is the most common type of cancer among women worldwide. The standard 
histopathology of breast tissue, the primary means of disease diagnosis, involves manual 
microscopic examination of stained tissue by a pathologist. Because this method relies on 
qualitative information, it can result in inter-observer variation. Furthermore, for difficult cases 
the pathologist often needs additional markers of malignancy to help in making a diagnosis. We 
present a quantitative method for label-free tissue screening using Spatial Light Interference 
Microscopy (SLIM). By extracting tissue markers of malignancy based on the nanostructure 
revealed by the optical path-length, our method provides an objective and potentially automatable 
method for rapidly flagging suspicious tissue. We demonstrated our method by imaging a tissue 
microarray comprising 68 different subjects - 34 with malignant and 34 with benign tissues. Three-
fold cross validation results showed a sensitivity of 94% and specificity of 85% for detecting 
cancer. The quantitative biomarkers we extract provide a repeatable and objective basis for 
determining malignancy. Thus, these disease signatures can be automatically classified through 
machine learning packages, since our images do not vary from scan to scan or instrument to 
instrument, i.e., they represent intrinsic physical attributes of the sample, independent of staining 
quality.   
Introduction: 
 The latest World Health Organization (WHO) figures have reported breast cancer as the 
second most common form of cancer worldwide with 522,000 deaths in 2012 1. Within the US 
over 200,000 new cases of the disease are expected for women in 2017 according to the American 
Cancer Society 2. Effective treatment strategies require timely and accurate diagnosis of the 
disease. It has been reported that, in the US, the 5-year average survival rates for patients with 
invasive breast cancers increase from 90% to 99% when the disease is detected at a localized (non-
metastatic) stage 3.   
 The standard tissue evaluation method for diagnosing breast cancers involves microscopic 
examination of a hematoxylin and eosin (H&E) counter-stained tissue biopsy. The biopsy 
specimen is obtained from the patient when suspicion of disease is noted during a screening 
procedure such as X-ray mammography. Since cells and histological tissue sections are 
transparent, the H&E stain provides the necessary contrast for assessing tissue morphology using 
a conventional bright field microscope. This standard histopathology process has two important 
short-comings: reliance on qualitative markers leads to intra- and inter-observer variation while 
manual examination can lower the throughput of the evaluation. Quantitative microscopy could 
help pathologists by offering an objective assessment of the tissue physical properties. 
Furthermore, quantitative markers can be interpreted by machine learning classifiers for rapid 
analysis and automated detection 4. 
 In this work, we present a method for extracting quantitative markers of malignancy in 
breast tissue biopsies using Spatial Light Interference Microscopy (SLIM) 5. SLIM is a quantitative 
phase imaging (QPI) 6 modality that generates contrast by measuring the variation of optical path-
length difference (OPD) across the tissue specimen. OPD reports on the product of the refractive 
index and thickness of tissue at each pixel. Malignant transformation involves physical changes in 
epithelial cell size and density as well as the tissue organization – both of which affect OPD maps 
of tissue. These maps have, therefore, been used in the past for several clinical investigations 7. 
This includes applications in histopathology and cytopathology including diagnosis of prostate 8 
and colorectal cancers 9,10, prediction of recurrence in prostate cancer 11, analysis of Gleason grade 
12, assessment of metastatic pancreatic cells 13 as well as detection of pre-malignancy in colorectal 
tissue 14. Furthermore, using QPI human blood cells have also been investigated for morphological 
15,16, chemical 16-18 and mechanical markers of disease 19,20. 
 To date, a majority of quantitative image analysis on breast tissue biopsies has relied on 
color images of stained tissue. Image classification in these cases has involved computing a wide 
range of histological features including geometric features 21,22, texture-related features 23,24 and 
radiometric features 23 25,26 [see 27 for a review of methods]. However, the feature extraction 
process relies heavily on tissue staining which can vary from sample to sample and instrument to 
instrument, affecting the robustness of the classifier 28. The label-free approach we propose makes 
classification through machine learning easier since the instrument does not require calibration for 
inconsistency in pixel values due to variations in staining, tissue changes caused by harsh solvents 
etc.  Other label-free quantitative methods for tissue image classification have been proposed in 
the literature, including Fourier transform infrared spectroscopy (FTIR) 29-31, Raman spectroscopy 
32-34, optical coherence tomography (OCT) 35,36 and second-harmonic generation  (SHG) imaging 
37,38. However, these techniques differ from our QPI-based method in terms of speed, resolution, 
and compatibility with the current diagnostic pipeline.  
 We demonstrated in our previous work 39 that SLIM captures sufficient tissue morphology 
to separate benign from malignant tissue via visual investigation by trained pathologists.  In this 
work, we demonstrate the quantitative analysis capabilities of our tissue screening system by 
imaging a tissue microarray (TMA) comprising 68 different cases (34 benign and 34 malignant). 
For each epithelial region within a tissue core, we extracted scattering, geometric, and texture-
related markers of tissue malignancy from the SLIM maps (see Materials and Methods). A linear-
discriminant analysis (LDA) classifier was trained to separate benign cases from malignant cases 
and three-fold cross validation was performed to measure the classification accuracy of the learned 
model 40,41. Using validation by the Receiver Operating Characteristic (ROC) curve analysis, our 
results revealed a sensitivity of 94% and specificity of 85%.        
Materials and Methods 
a. SLIM Optical Setup 
 Figure 1 illustrates the SLIM optical setup which has been discussed in detail in previous 
publications 5,42. The setup comprises of a module (CellVista SLIM Pro, Phi Optics, Inc.) coupled 
to the output port of a commercial phase contrast microscope (Carl Zeiss, Axio Observer Z1). 
This compatibility with existing microscopes promises to reduce barriers to clinical adoption 
since optical microscopes are commonly available in pathology labs. In the SLIM module, the 
conjugate image plane outside the microscope is relayed onto a CCD camera (Andor, Zyla) using 
a 4f system comprising lenses L1 and L2. At the Fourier plane of L1, a spatial light modulator 
(Boulder Nonlinear Systems) is used to modulate the phase difference between the scattered and 
unscattered components of light in increments of π/2. Four different modulations are applied [Fig. 
1 (b)] and the resulting phase image is reconstructed using a previously published algorithm 5. 
Using a software platform developed in-house, the SLIM module has been upgraded with full-
slide scanning capabilities 9,39. The acquisition speed is in the range of the existing commercial 
tissue scanners, which, in turn, only perform bright field imaging 39. Throughout our experiments, 
a 40x/0.75 NA phase contrast objective was used for imaging. 
 
Figure 1. (a) The SLIM module added on to a commercial phase contrast microscope. (b) Four 
frames are acquired to compute one phase image by modulating the phase difference between 
scattered and incident light using a spatial light modulator (SLM). (c) An image of the whole 
slide scanned using SLIM. (d) Example of a TMA core SLIM image. (e) Bright field image of 
the same core after H&E staining. BS, beam splitter; L1-L2, lenses; IP, image plane. 
 
b. Tissue microarray  
 The TMA used for our study was purchased from US Biomax Inc. (Serial # BR-1002) with 
diagnosis for each case provided by the manufacturer. The TMA was obtained with all human 
subject information de-identified. Neither the authors of this work nor their institutions were 
involved in the collection of tissue. The TMA comprised of cores 1 mm diameter and a section 
thickness of 5 µm. Standard formalin fixation and paraffin embedding (FFPE) histological 
preparation was used for each tissue block before extraction of cores. A xylene based mounting 
medium was used during cover-slipping. 
 The TMA consisted of 36 cases of infiltrating ductal carcinoma (IDC) and 36 cases of 
tumor adjacent normal tissue (one core per case – a total of 72 cores). Three of the tumor adjacent 
normal cores were obtained from the IDC cohort. In addition, 10 normal cases were included 
(single core each) from autopsy procedures. For final analysis we selected 34 cores diagnosed as 
malignant and 34 cores diagnosed as normal (either tumor adjacent normal or normal). The 
selection criteria were based on whether the core was intact and whether any epithelial tissue was 
present in the core (cores containing only stromal tissue were excluded). A SLIM image of the 
whole TMA slide is illustrated in Fig 1 (c) while Figs. 1 (d) and (e) show, respectively, phase map 
and H&E stained tissue bright field image (henceforth referred to as ‘H&E image’) of one core. 
For obtaining a mosaic of the TMA, we used a C++ based stitching code, developed in-house 9. 
After staining the same tissue slide using standard protocols 43, H&E images of the TMA were 
acquired using a bright-field microscope (Carl Zeiss, Axio Observer Z1) outfitted with a color 
camera (Carl Zeiss, Axiocam MRC). The H&E images were used to assist with annotation of 
epithelial regions in tissue, discussed below.  
 
c. Annotation of epithelial regions in tissue images 
 Glands or continuous epithelial regions within each core were manually annotated using 
the region of interest (ROI) tool of ImageJ to allow feature extraction for each gland. A consistent 
criterion for annotation was used where groups of epithelial cells bounded by stroma on all sides 
where considered a single gland. Other tissue components within epithelium (such as lumen etc.) 
were considered part of the gland if bounded on all sides by epithelial cells. Glands from cores in 
the IDC cohort were labelled as malignant while those from cores in the tumor adjacent normal 
cohort were labelled as benign. 
d. Extraction of geometric and scattering features 
 Malignant transformation in breast tissue affects the size, shape and density of epithelial 
cells as well as the shape and organization of epithelial tissue. As a result, both the geometry and 
scattering properties of the gland are affected. We used gland perimeter curvature C , as well as 
the mean scattering length sl  as part of the feature set used for separating benign and malignant 
tissue. The parameter extraction process is illustrated in Fig. 2 and a detailed description for each 
is provided below. 
 The extrinsic curvature C  of a two-dimensional plane curve ( , )P x y , that is parametrized 
by Cartesian coordinates ( )x t  and ( )y t  with parameter t , is given by the expression 44 
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where the 'x , 'y  and ''x , ''y  refer to the first and second derivatives in t , respectively. In the above 
parametrization, t  refers to each pixel comprising the curve ( , )P x y , having coordinates ( )x t  and 
( )y t . This curvature can be interpreted as the magnitude of the rate of change of a vector tangent 
to ( , )P x y . We computed C  for the perimeter ( , )P x y  of each annotated gland by using an open 
source MATLAB code 45. The code approximates ( , )P x y  as a polygon before computing C  for 
each point defining the gland perimeter, as described in Eq. (1). To speed up computation, the 
image of each core was first down-sampled from the raw image size of 8000 x 8000 to 2048 x 
2048 pixels. The perimeter ( , )P x y was then further down-sampled by a factor 20 before computing 
C  in order to remove any pixel level errors due to manual annotation. The median gland curvature 
C  was then used as a feature for separating benign and malignant cases. Figs. 2 (c) and (d) 
illustrate C  for representative benign and malignant glands.  
 The mean scattering length sl  is a bulk scattering parameter that defines the length scale 
over which a single scattering event occurs on average. Assuming that the tissue slice captures the 
refractive index spatial fluctuation statistics, i.e., assuming statistical homogeneity, sl can be 
computed through the scattering-phase theorem using the expression 46 
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where ( , )x yφ  is the SLIM phase image, L  is the tissue section thickness and the operator [ ]var .  
computes the spatial variance over a region. The sl  parameter has been used in the past for 
discriminating between benign and malignant prostate tissue 8. We first computed the image 
( , )sl x y  using a variance filter kernel size of 149 x 149 pixels, which equals the approximate 
diameter of 3 epithelial cells. The feature sl  was then computed by calculating the median of 
( , )sl x y  over the gland area. This computation is illustrated in Figs. 2 (e) and (f). 
 
 Figure 2. Computing the geometric feature C  and scattering feature sl over each annotated 
gland. (a) and (b) H&E images of benign and malignant glands, respectively. (c) and (d) SLIM 
images of the same benign and malignant glands, respectively, illustrating gland curvature C . 
The median over gland C is used as the geometric feature for classification. (e) and (f) ( , )sl x y
for benign and malignant glands, respectively. The median over gland sl is used as the 
scattering feature for classification. 
 
e. Extraction of texture-related features 
 Benign and malignant epithelial tissues differ not only in cell morphology but also in the 
organization of their components, leading to different textures. Texture-related features have been 
used in the past for solving different classification problems in histopathology of cancers 12,27. Our 
feature extraction follows the work done by Varma et al. 47 for classifying different materials based 
on their texture. The approach is illustrated in Fig. 3. A TMA core phase image [Fig. 3 (a)] is first 
filtered through a convolution with the Leung-Malik (LM) filter bank [Fig. 3 (b)]. This filter bank 
consists of gradient filters (both odd and even) at different orientations and spatial scales 48 . In 
total, 58 different filters were used, generating a 58-dimensional response vector for each pixel in 
the core phase image [Fig. 3 (c)]. K-means clustering was then performed on the response vectors 
(number of clusters, K = 50) generated from all cores within the training set and the computed 
cluster centroids were referred to as ‘textons’ 47,48. Since each pixel in the core belongs to a texton, 
for each pixel the histogram of textons was generated for its vicinity (window size 60 x 60 pixels) 
and was used to characterize the local texture in that neighborhood. This way, a 50 dimensional 
feature vector T  was generated to characterize texture in a pixel’s neighborhood. An open source 
MATLAB code was used for generating the LM filter bank for this work 49.  
 
Figure 3. Algorithm for computing the texture in a pixel’s neighborhood. (a)-(c) Generating the 
response of each pixel to a Leung-Malik filter bank. (d) K-means clustering of response vectors, 
generated from all cores in the training set, in order to find 50 cluster centroids or textons. (e) 
Histogram of textons, within a pixel’s neighborhood, comprise the texture-related feature vector 
T for each pixel. 
 
 
 
 
 
 
f. Classifier training and validation 
 Since our work involves classifying each gland within a tissue core as benign or malignant, 
a feature vector for each gland was next generated by concatenating geometric, scattering and 
texture-related features. This procedure is illustrated in Fig. 4. After pixel-wise computation of 
gland curvature C , scattering length sl  and texture vector T , the median of each feature was 
computed over each gland in a core and a combined 52 dimension feature vector was generated 
for training. For each gland, this feature vector was then used as a predictor for training a linear-
discriminant analysis (LDA) classifier [Fig. 4(a)]. Class labels, either benign or malignant, were 
used as the ground-truth for each gland during the training process. 
 The feature extraction for validation purposes, illustrated in Fig. 4 (b), followed a nearly 
identical procedure to that used during training. The only difference was that, instead of finding 
new textons (cluster centroids) for validation data, the texture feature vector T was computed by 
using the same textons as determined during training. As in training, a 52 dimensional feature 
vector was input to the LDA classifier which then used the model learned during training to 
generate a likelihood score for a gland being benign or malignant. Finally, the mean of the 
likelihood scores of all glands within a core was computed and used as the likelihood score of a 
core being benign or malignant. These scores were then used to generate a receiver operative 
characteristic (ROC) to select an operating point for separating benign and malignant cases (see 
Results and Discussion). 
 
 
 
Figure 4. (a) Training and (b) Validation procedure for classifying glands as benign or 
malignant. 
 
Results and Discussion 
 
 The classification results of our analysis are summarized in Fig. 5. In order to  evaluate the 
accuracy of our method, we performed three-fold cross-validation 50 as illustrated in Fig. 5 (a). 
The total number of cases were divided into three (nearly) equal groups. In each trial, two groups 
were used for training while the remaining one was used for validation. Thus, three validation 
trials were performed, each time selecting a different validation/training set combination.  
 Figure 5 (b) illustrates the separation between benign and malignant gland feature vectors 
in one training set. In order to illustrate the data separation in 3 dimensions, we use principal 
component analysis (PCA) and represent the 50-dimensional feature vector T  through its first 
principal component PC1 T . The training space shows that scattering feature sl  has on average 
higher values for malignant glands than for benign glands. This finding is compatible with typical 
gland morphology in breast tissue since benign glands are well differentiated, consisting of a 
number of different structures including epithelial cells, lumen and myoepithelial cells 51. This 
heterogeneity of structure results in short mean scattering lengths as explained by a large variance 
in Eq. (2). Malignant glands on the other hand consist of a monoclonal proliferation of cells, 
sometimes even showing sheets of poorly differentiated epithelial cells, resulting in smaller 
variance and larger sl  values 51.  These phenomena can also be observed in the examples given in 
Figs. 2 (e) and (f). In previous investigations on prostate cancer, it was shown that sl  has a lower 
value in malignant tissue than in benign tissue 8. That analysis, however, was carried out on larger 
areas of tissue where cellular organization can be different from the epithelial only regions we are 
studying in this work 8.  
 The median gland curvature C , on the other hand, generally has higher values for benign 
glands than for malignant glands. This is a result of the fact that the edge of a benign gland is 
constrained to follow a round or elliptical shape due to tubule formation [Figs. 2 (a) and (c)] 51. 
When malignant transformation occurs, this constraint is broken and the gland edge is more 
irregular. At the spatial scale of investigation we have used here (approx. 13 mµ ), the perimeter of 
the malignant gland is less rapidly varying, on average, than that of a benign gland. This geometric 
feature is similar to the previous measurement of the gland perimeter fractal dimension that has 
been used for histopathology 21,27.  
 Fig. 5 (c) shows the separation between benign and malignant glands in the validation 
feature space, where, qualitatively, the same separation trend is seen as in training. We show the 
results of only one of the three validation trials that were carried out. As described in Materials 
and Methods, the gland likelihood scores, generated by the classifier during validation, were 
averaged over each gland in order to obtain core-wise or case-wise scores.  The core-wise 
likelihood scores from the 3 trials were then pooled together to generate the ROC curve illustrated 
in Figure 5 (d) 52. Our results indicate an area under the curve (AUC) of 0.91. The optimum 
operating point for classification was determined by assigning equal weight to the cost of 
misclassifying positives and the cost of misclassifying negatives 53. This resulted in a sensitivity 
of 0.94 and specificity of 0.85 for the three-fold cross validation. The higher sensitivity of 0.94 is 
appropriate for our screening application, as a diagnostic tool based on this method will generate 
a small number of false negatives. Such a tool can point out tissue areas that have even a small 
chance of malignancy so a pathologist can inspect them more closely. 
  
 
 
Figure 5. (a) Three-fold cross-validation procedure for evaluating classification accuracy. (b) 
Separation of benign and malignant gland feature vectors during training in 1 of 3 validation 
trials. (c) Separation of benign and malignant gland feature vectors during validation in 1 of 3 
validation trials. (d) ROC curve for the 3 validation trials resulting in a sensitivity of 0.94 and 
specificity of 0.85 at the optimum operating point. 
 
 
Summary and Conclusions 
 In summary, we presented a new method for screening tissue biopsies obtained from 
patients under investigation for breast cancer. Since our method relies on measurement of OPD 
maps, an intrinsic property of tissue, the basis for classification is objective and not subject to inter-
observer variation. While in the past much of the quantitative histopathology has relied on analysis 
of stained tissue, our method performs image processing and machine learning on unlabeled 
images, making it insensitive to variability due to staining. Thus, the process of automating the 
entire method is feasible and subject to our future efforts.  
 While other label-free diagnosis methods have been proposed for these types of 
investigations, they affect the standard diagnostic pipeline in terms of either speed, resolution or 
compatibility with established workflow. SLIM, on the other hand, requires minimal changes to a 
conventional microscopic optical train due to its modular design. Equipped with a slide-scanning 
feature for rapid acquisition, a SLIM tissue scanner can potentially carry out high-throughput 
automated histopathology, not only reducing the case-load for pathologists but also providing 
complementary information through new markers. This carries the potential for incorporation into 
daily practice of diagnostic surgical pathology, either as a screening method to point out areas of 
the slide that need additional attention, or for difficult cases where pathologists need supporting 
tests to make a final diagnostic decision. 
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Figure Legends: 
Figure 1. (a) The SLIM module added on to a commercial phase contrast microscope. (b) Four 
frames are acquired to compute one phase image by modulating the phase difference between 
scattered and incident light using a spatial light modulator (SLM). (c) An image of the whole slide 
scanned using SLIM. (d) Example of a TMA core SLIM image. (e) Bright field image of the same 
core after H&E staining. BS, beam splitter; L1-L2, lenses; IP, image plane. 
 
Figure 2. Computing the geometric feature C  and scattering feature sl over each annotated 
gland. (a) and (b) H&E images of benign and malignant glands, respectively. (c) and (d) SLIM 
images of the same benign and malignant glands, respectively, illustrating gland curvature C . The 
median over gland C is used as the geometric feature for classification. (e) and (f) ( , )sl x y for 
benign and malignant glands, respectively. The median over gland sl is used as the scattering 
feature for classification. 
 
Figure 3. Algorithm for computing the texture in a pixel’s neighborhood. (a)-(c) Generating the 
response of each pixel to a Leung-Malik filter bank. (d) K-means clustering of response vectors, 
generated from all cores in the training set, in order to find 50 cluster centroids or textons. (e) 
Histogram of textons, within a pixel’s neighborhood, comprise the texture-related feature vector 
T for each pixel. 
Figure 4. (a) Training and (b) Validation procedure for classifying glands as benign or malignant. 
 
Figure 5. (a) Three-fold cross-validation procedure for evaluating classification accuracy. (b) 
Separation of benign and malignant gland feature vectors during training in 1 of 3 validation trials. 
(c) Separation of benign and malignant gland feature vectors during validation in 1 of 3 validation 
trials. (d) ROC curve for the 3 validation trials resulting in a sensitivity of 0.94 and specificity of 
0.85 at the optimum operating point. 
